(2024). Prognostic factors for colchicine prophylaxis-related adverse events when initiating allopurinol for gout: retrospective cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keae229
. R. Bajpai
First name
R.
Last name
Bajpai
(2024). Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study. Pain. http://doi.org/10.1097/j.pain.0000000000003239
. (2023). Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink. Ann Rheum Dis. http://doi.org/10.1136/ard-2023-224154
. (2023). Trends in consultations and prescribing for rheumatic and musculoskeletal diseases: an electronic primary care records study. Br J Gen Pract, 73, e858-e866. http://doi.org/10.3399/bjgp.2022.0648
. (2023). The impact of the COVID-19 pandemic on referrals to musculoskeletal services from primary care and subsequent incidence of inflammatory rheumatic musculoskeletal disease: an observational study. Rheumatol Adv Pract, 7, rkad044. http://doi.org/10.1093/rap/rkad044
. (2020). Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction. Heart. http://doi.org/10.1136/heartjnl-2019-315511
. (2021). Rheumatic Conditions as Risk Factors for Self-Harm: A Retrospective Cohort Study. Arthritis Care Res (Hoboken). http://doi.org/10.1002/acr.24345
.